Amed Co., Ltd. (TPEX:7575)

Market Cap	843.00M -32.7%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	30.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	1.50 (5.36%)
Ex-Dividend Date	Jun 16, 2025

Volume	17,002
Average Volume	154,360
Open	28.00
Previous Close	28.25
Day's Range	27.90 - 28.35
52-Week Range	25.50 - 43.50
Beta	-0.26
RSI	49.78
Earnings Date	n/a

About Amed Co., Ltd.

Amed Co., Ltd. engages in the research and development, manufacture, and trading of medical equipment in Taiwan. It offers wound care dressing products under the HERADERM brand name; negative pressure wound therapy systems that provides 24-hour oxygen supply to wounds under the Genadyne brand name; and wound treatment systems under the Natrox brand name. The company also provides 7-day long-acting pain reliever injections under the Naldebain brand name. In addition, it offers pressure injectable implantable port kits under the POLYSITE brand; a...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2008
• Employees: 165
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7575